0.2~8mg/L Cystatin C Detection Reagent (Immunofluorescence Chromatography) (CysC) In Internal

CysC overview

The cysteine proteinase inhibitor (CPI) is named cysteine C. Cystatin C in the circulation is only cleared by glomerular filtration. It is an endogenous marker that reflects changes in glomerular filtration rate. It is reabsorbed in the proximal convoluted tubules, but is completely absorbed after reabsorption. Metabolism is decomposed and does not return to the blood. Therefore, its blood concentration is determined by the glomerular filtration rate and does not rely on any external factors, such as gender, age, and diet. It is a reflection of changes in the glomerular filtration rate Ideal endogenous marker.

CysC performance index

Clinical significance of CysC

• Early diagnosis and monitoring of kidney disease
• Assessment of renal function in high-risk groups of AKI
• Detection of renal function in the management of chronic diseases

Sensitivity comparison of cystatin C and serum creatinine in the evaluation of GFR

Application Department

gynecology, obstetrics and Gynecology, emergency, ICU, Nephrology, oncology, surgery, etc

Clinical comparison of CysC

Company profile

Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.

Zhongxiu Science And Technology Co.,Ltd., founded in 2016, is located in Dingluan Industrial Zone, Changyuan City, Henan Province. The company covers an area of about 100 acres and the initial investment is about 200 million yuan. The company has a scientific and complete management system, a purification workshop of national standards, and a fully functional inspection center. On this basis, the company will continue to invest in research and development, accumulate technical strength, update manufacturing equipment, improve production technology, improve inspection technology, improve product quality, and provide customers with safe and effective in vitro diagnostic products.

Zhongxiu Science And Technology Co., Ltd. is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, immune series, microbial series and other reagents and supporting instruments.

The company has always adhered to the core concept of “fast and accurate, living up to life”, committed to providing society with excellent products and services, and contributing to the cause of human health.